Volume 10, Issue 4 (2019)                   JMBS 2019, 10(4): 647-654 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karimian Bahnamiri S, Maghsoudi A, Yazdian F. Fabrication of Polymeric PAA, PVA, and PEI Nanoparticles Loaded with the Natural Antibacterial Component, Curcumin, and Their Effectiveness against Methicillin Resistant Staphylococcus aureus. JMBS 2019; 10 (4) :647-654
URL: http://biot.modares.ac.ir/article-22-33412-en.html
1- Institute of Environmental & Industrial Biotechnology, National Institute of Genetic Engineering & Biotechnology, Tehran, Iran
2- Institute of Environmental & Industrial Biotechnology, National Institute of Genetic Engineering & Biotechnology, Tehran, Iran, Institute of Environmental & Industrial Biotechnology, National Institute of Genetic Engineering & Biotechnology, Tehran, Iran , maghsoudi.a@gmail.com
3- Life Science Engineering Department, New Science & Technologies Faculty, University of Tehran, Tehran, Iran
Abstract:   (4007 Views)
Aims: Curcumin is a natural molecule that due to its various curative effects including antibacterial properties, it can be used as a medicine, albeit after reducing its disadvantages. The aim of the present study is to develop a method for preparation of nanoparticles of curcumin using PAA, PVA, and PEI polymers with a view to improve its stability, increasing bioavailability and aqueous solubility as well as study its effectiveness against methicillin-resistant to Staphylococcus aureus.
Materials & Methods: In order to synthesize polymeric nanoparticles including curcumin with the nano-precipitation method, optimizing the effective concentration of polymer, curcumin, and water were determined by using the Response Surface Method (RSM). Synthesized nanoparticles were characterized by Scanning Electron Microscope (SEM), Dynamic Light Scattering (DLS) and zeta potential measurement methods. Furthermore, minimal concentration inhibitory of synthesized nanoparticles against the Staphylococcus aureus resistant to methicillin was measured.
Findings: The created nanoparticles were round, discrete and smooth in surface morphology and the average particle size for PAA, PVA, and PEI were 149±7nm, 175±8nm, and 184±9nm respectively. The minimum inhibitory concentration for PAA, PVA and PEI nanoparticles against the Staphylococcus aureus were 0.480±0.024, 0.390±0.019 and 0.340±0.017mg/ml. The concentration of solvent, polymer, and curcumin was important to obtain small size particles.
Conclusion: The results indicated that the water solubility of curcumin significantly improved by particle size reduction up to the nano range. The inhibitory property of curcumin nanoparticles has greatly increased due to the smaller particle size and their increased penetration into the bacteria and nanoparticles loaded with curcumin could be a promising drug carrier for the treatment of cancer, infections and other diseases.
Full-Text [PDF 1097 kb]   (1869 Downloads)    
Article Type: Original Research | Subject: Nanotechnology
Received: 2019/05/29 | Accepted: 2019/06/15 | Published: 2019/12/21

1. World Health Organization. The global epidemiology of infectious diseases. Murray CJL, Lopez AD, Mathers CD, editors. 4th Volume. Geneva: World Health Organization; 2004. [Link]
2. Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8-9):714-8. [Link] [DOI:10.1016/j.phymed.2013.02.006]
3. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine. 2003;82(5):322-32. https://doi.org/10.1097/01.md.0000091184.93122.09 [Link] [DOI:10.1097/01.md.0000091185.93122.40]
4. Liu J, Xu L, Liu Ch, Zhang D, Wang S, Deng Z, et al. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohydr Polym. 2012;90(1):16-22. [Link] [DOI:10.1016/j.carbpol.2012.04.036]
5. Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056-61. [Link] [DOI:10.1021/jf104402t]
6. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6(1):10. [Link] [DOI:10.1186/1472-6882-6-10]
7. Shome S, Talukdar AD, Choudhury MD, Bhattacharya MK, Upadhyaya H. Curcumin as potential therapeutic natural product: A nanobiotechnological perspective. J Pharm Pharmacol. 2016;68(12):1481-500. [Link] [DOI:10.1111/jphp.12611]
8. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: Development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6(5):1388-401. [Link] [DOI:10.1021/mp900056g]
9. Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2(5):395-401. [Link] [DOI:10.4161/viru.2.5.17035]
10. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials. 2000;21(23):2475-90. [Link] [DOI:10.1016/S0142-9612(00)00115-0]
11. Leardi R. Experimental design in chemistry: A tutorial. Anal Chim Acta. 2009;652(1-2):161-72. [Link] [DOI:10.1016/j.aca.2009.06.015]
12. Rajasimman M, Sangeetha R, Karthik P. Statistical optimization of process parameters for the extraction of chromium (VI) from pharmaceutical wastewater by emulsion liquid membrane. Chem Eng J. 2009;150(2-3):275-9. [Link] [DOI:10.1016/j.cej.2008.12.026]
13. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85-94. [Link] [DOI:10.1016/j.tips.2008.11.002]
14. Akram M, Shahab-Uddin AA, Usmanghani K, Hannan A, Mohiuddin E, Asif M. Curcuma longa and curcumin: A review article. Rom J Biol Plant Biol. 2010;55(2):65-70. [Link]
15. Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. In: Aggarwal BB, Surh YJ, Shishodia Sh, editors. The molecular targets and therapeutic uses of curcumin in health and disease. Boston: Springer; 2007. pp. 453-470. [Link] [DOI:10.1007/978-0-387-46401-5_20]
16. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 2004;1(1):115-25. [Link] [DOI:10.1586/17434440.1.1.115]
17. Adahoun MA, Al-Akhras MAH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45(1):98-107. [Link] [DOI:10.3109/21691401.2015.1129628]
18. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. Coping with antibiotic resistance: Combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 2011;9(11):1035-52. [Link] [DOI:10.1586/eri.11.121]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.